12 results
10-K
2019 FY
GRTX
Galera Therapeutics Inc
10 Mar 20
Annual report
7:36am
to patients;
the product may become less competitive; and
our reputation may suffer.
Any of the foregoing events could prevent us from achieving … develop;
injury to our reputation and significant negative media attention;
regulatory investigations that could require costly recalls or product
10-Q
2019 Q3
GRTX
Galera Therapeutics Inc
10 Dec 19
Quarterly report
7:31am
; and
our reputation may suffer.
Any of the foregoing events could prevent us from achieving or maintaining market acceptance of the particular … candidates that we may develop;
injury to our reputation and significant negative media attention;
regulatory investigations that could require costly
424B4
rv3jo0
8 Nov 19
Prospectus supplement with pricing info
4:41pm
S-1/A
ok3cmwithz5yxq
28 Oct 19
IPO registration (amended)
7:16am
S-1
af36a0yic7u xnuy
11 Oct 19
IPO registration
5:27pm
DRS/A
sjx26j1b ba6
12 Sep 19
Draft registration statement (amended)
12:00am
DRS/A
tzy3ag690mt0jz
9 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
8h6gyt
23 Apr 19
Draft registration statement (amended)
12:00am
DRS
n9pcxyhsdcjx2 729
15 Mar 19
Draft registration statement
12:00am
- Prev
- 1
- Next